Therapeutic agent for tumor
AssigneesAsahi Kasei Pharma Corporation, National Cancer Center
InventorsTakahiro Ochiya, Ryou-u Takahashi
Life of this patent
Estimating the term…
Abstract
The present invention provides a therapeutic agent for a tumor, particularly a therapeutic agent for drug-resistant cancer, an agent for suppression or prophylaxis of tumor metastasis, and an agent for suppression or prophylaxis of cancer recurrence, containing a nucleic acid containing miR27b or a nucleotide having a nucleotide sequence having an identity of 70% or more with the nucleotide sequence shown by SEQ ID NO: 1 and having a function equivalent to miR27b.
Claims16
A method of treating a tumor, comprising administering a nucleic acid comprising miR27b or a nucleotide having a nucleotide sequence having an identity of 70% or more with the nucleotide sequence shown by SEQ ID NO:
- 1 and having a function equivalent to miR27b.
A method of treating a tumor, comprising administering (A) a nucleic acid comprising miR27b or a nucleotide having a nucleotide sequence having an identity of 70% or more with the nucleotide sequence shown by SEQ ID NO:
- 1 and having a function equivalent to miR27b, and (B) an antitumor agent in combination.
16-25. (canceled)
Dependencies are inferred from the claim text.